Reports Q1 revenue $596.4M, consensus $570.62M.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BMRN:
- BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues
- William Blair biotech analyst to hold an analyst/industry conference call
- BioMarin granted orphan status for DMD treatment
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations